A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy Subjects

Clinical trial NCT05294458 · COMPLETED

Trial details

NCT number: NCT05294458
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-alcoholic Steatohepatitis Type 2 Diabetes Mellitus (T2DM)Chronic Kidney Disease

Start date: 2022-03-28
Primary completion: 2022-09-12
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.